PKPamela K. Kohler

Pamela K. Kohler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pamela K. Kohler has a total of 234 co-authors. Here are the top co-authors by number of shared publications:

  • Grace John-Stewart

    Department of Global Health, University of Washington, Seattle, WA

    8 shared publications
  • Barbra A. Richardson

    Affiliations Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Biostatistics, University of Washington, Seattle, Washington, United States of America

    6 shared publications
  • Grace John-Stewart

    Department of Global Health, University of Washington, Seattle, USA

    6 shared publications
  • Irene Inwani

    University of Washington Seattle Washington USA

    5 shared publications
  • Jacinta Badia

    Affiliation Impact Research and Development Organisation, Kisumu, Kenya

    5 shared publications
  • Kristin Beima-Sofie

    Affiliation Department of Global Health, University of Washington, Seattle, Washington, United States of America

    5 shared publications

Latest Publications

  • Open Access

    A Qualitative Study of Perceived Barriers to Hepatitis C Care Delivery Among Health Providers in Washington State

    by Paula Cox-North, Lisa Wiggins, Deepa Oja, Emalie Huriaux, Jon Stockton, Omeid Heidari, Leta Evaskus, Donna Sullivan, Stella Chang, Anirban Basu, et al.

    With the arrival of direct-acting antivirals, the implementation of universal hepatitis C virus screening, and simplified treatment protocols, the landscape for managing hepatitis C has become less complicated and more adaptable to primary care settings. In 2019, Washington State created and implemented a statewide comprehensive plan aimed at eliminating hepatitis C by 2030. This study aims to understand provider-based perceptions about screening and treating hepatitis C, and how these perceptions influence care across Washington State. This is a qualitative study using semi-structured in-depth interviews exploring screening and treatment practices of health providers across Washington State. Qualitative data collection was guided by the Updated Consolidated Framework for Implementation Research. Data was analyzed using thematic analysis to identify key factors. Fourteen providers participated in interviews. Most providers (86%) treated hepatitis C, and (71%) of those providers also treated substance use disorders. Emerging themes included organizational barriers, patient barriers, provider barriers, and stigma. Healthcare provider shortages, high turnover in rural parts of the state, lack of provider knowledge about current guidelines and access to information, patient competing priorities, and lack of updated screening and treatment care models were identified as strong barriers to treatment implementation.

  • Open Access

    Psychosocial correlates of adherence self-efficacy and HIV viral suppression among adolescents and young adults in Western Kenya

    by Deepa Oja, Wenwen Jiang, Barbra A. Richardson, Jacinta Badia, James Kibugi, Kristin Beima-Sofie, Sarah Hicks, Jillian Pintye, Molly R. Altman, Kawango Agot, et al.

    Objective: To measure adherence self-efficacy (ASE) to antiretroviral therapies (ART) and evaluate the relationship between ASE, depression, perceived social support, and HIV viral suppression among adolescents and young adults living with HIV (ALHIV) in Kenya. Design: Cross-sectional analysis of baseline data from a longitudinal cohort of Kenyan ALHIV. Methods: ALHIV were recruited from nine health facilities in western Kenya. Participants completed behavioral surveys at enrollment, and study team members extracted viral load data from a national database. ASE was assessed using a modified HIV-Adherence Self-efficacy Assessment Survey (HIV-ASES), and depression was assessed as a score of ≥ 10 using the PHQ-9. Linear mixed effects regression modeling and general linear mixed effects regression modeling, clustering by facility, were used to determine associations between ASE scores, viral suppression, and correlates of interest. Results: Overall, 987 ALHIV age 15 and older were included in this study, 70% were female, 58% ages 15−19, and 57% were attending or had completed at least secondary school. Ninety-six percent had ASE data, 73% (517/703) were virally suppressed, 90% (888/987) scored 9 or below on the PHQ-9, 47% (460/987) reported high perceived social support, and 65% (645/987) were classified as having orphan status. ALHIV who had moderate-to-severe depression had a mean ASE score that was 13.41 points lower (95% CI: −20.12 – −6.52, p < 0.001) than those with none-or-mild depression. Female ALHIV had higher odds of viral suppression (adjusted OR: 1.55, 95%CI: 1.07–2.25, p = 0.02) as did ALHIV with higher social support (adjusted OR: 1.67, 95%CI: 1.17–2.40, p = 0.005). There was no significant association identified between ASE and viral suppression. Conclusions: Emotional well-being and social support are essential to improve adherence self-efficacy and viral suppression among youth living with HIV.


  • Open Access

    Trends in Utilization and Costs Following a Hepatitis C Elimination Initiative

    by Ashley Tabah, Anirban Basu, Paula Cox-North, Judy Zerzan-Thul, Leta Evaskus, Donna Sullivan, JoEllen Colson, Emalie Huriaux, Jon Stockton, Omeid Heidari, et al.

    Importance: Expanded screening and treatment options as part of national guidelines and statewide policy initiatives have the potential to eliminate hepatitis C virus (HCV). Objective: To describe trends in HCV screening, prevalence, treatment, and costs before and after Washington State’s HCV elimination initiative. Design, Setting, and Participants: This case series is an observational analysis of retrospective claims data aggregated at the individual-month level. The dataset included individuals in the Washington State All Payers Claims Database between January 2017 and September 2022. Analyses were conducted from August to November 2025. Exposures: In July 2019, as part of a directive from the governor, the Washington State Department of Health released a comprehensive HCV elimination strategy. The plan included discounted and subscription-based payment models and removal of restrictive prior authorization and specialist consultation requirements. Main Outcomes and Measures: International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) and Current Procedural Terminology codes were used to identify HCV testing or screening, ICD-10 diagnosis codes were used for HCV infections, and the National Drug Codes were used for HCV direct-acting antiviral medications. An individual was considered to have newly diagnosed HCV at the earliest month in which they had an HCV test claim followed by 2 HCV diagnosis codes within the subsequent 12 months and no HCV diagnosis during the 6 months before the test month. Total health care costs per month were computed, excluding cost of HCV direct-acting antiviral medications. Interrupted time-series approaches computed trends over time using the second quarter (Q2) of 2019 as a reference time point. Results: More than 21 million unique individuals (mean [SD] age, 44 [26] years; 11 085 080 female [53%]) were included in the data extraction. The number of HCV tests per month was stable during the preinitiative and immediate postinitiative period. Beginning in 2020 Q3, screening increased significantly from the reference quarter by 10.5 additional tests per month per 1000 Washington enrollees (95% CI, 8.8 to 12.2 tests per month per 1000 enrollees; P < .001). Consistent with increased screening, the prevalence of chronic HCV cases increased through 2021, but declined by 0.4 cases per 1000 enrollees comparing 2019 Q2 to 2022 Q3 (95% CI, −0.6 to −0.2 cases per 1000 enrollees; P < .001). The proportion of newly diagnosed cases receiving any HCV treatment increased from 16.8% (634 of 3776 cases) in 2017 to 24.9% (472 of 1894 cases) in early 2021 (difference, 8.1 percentage points; 95% CI, 5.8 to 10.4 percentage points; P < .001), but slopes before and after 2019 Q2 were not significantly different. Costs per ever prevalent case decreased significantly by 2021 Q1 (−$520 per month compared with 2019 Q2; 95% CI, −$922 to −$124 per month; P = .01). Conclusions: In this longitudinal case series analysis of claims data, Washington State’s elimination initiative, combined with revised national screening guidelines and improved treatment options, contributed to expansion of HCV screening and changes over time in the proportion of people identified and treated for HCV, as well as decreased overall care costs.


  • Open Access

    Mental health service delivery among adolescent girls and young women (AGYW) seeking HIV prevention and treatment services in central Kenya: A qualitative study of AGYW and healthcare providers’ perceptions

    by Emmah Owidi, Kenneth Ngure, Peter Mogere, John Njoroge, Snaidah Ayub, Roy Njiru, Boaz Kipkorir, Edinah Casmir, Catherine Kiptinness, Tessa Concepcion, et al.

    Introduction: Common mental disorders (CMDs) are prevalent among adolescent girls and young women (AGYW) in high HIV-burden settings. However, mental health is underprioritized within HIV interventions targeting AGYW. We conducted a qualitative study to explore AGYW and healthcare providers’ perceptions of mental health service delivery within HIV clinics. Methods: Between 16th February and 14th June 2021, we conducted in-depth interviews with AGYW receiving HIV services and healthcare providers from eight clinics in Central Kenya. Eligible AGYW were aged 16–25 years and reported mild-to-moderate CMD symptoms, determined by the Self-Reporting Questionnaire 20-item (SRQ-20) mental health screening tool. Eligible providers currently provided HIV or mental health services. Interviews explored AGYW’s experiences with CMDs and factors influencing mental health service delivery by providers within HIV clinics. We analyzed data deductively and inductively using thematic analysis and organized findings using the socio-ecological model. Results: Median age among AGYW (n = 20) was 21 years (IQR:18–24), and SRQ-20 screening score was 9 (IQR: 8–11). Providers (n = 10) comprised seven females; and included six HIV and four mental healthcare providers. AGYW described experiences of CMDs due to multi-level risk factors, including HIV stigma, financial problems, and relationship challenges. AGYW reported a high demand for mental health services but described a systemic lack of access. Convenience and positive experiences with providers facilitated AGYW’s access to services. Conversely, HIV care providers felt less confident in delivering mental health services due to inadequate mental health training compared to mental healthcare providers. Providers also reported inadequate training, poor referral systems, and unclear guidelines that hindered service delivery. AGYW and providers endorsed mental health service integration within HIV clinics to potentially reduce referral burden for AGYW and improve service quality. Conclusions: Our findings highlight gaps in mental health service delivery among AGYW receiving HIV services. Integrated service delivery within HIV clinics could improve AGYW’s access to mental health services.

  • Open Access

    Data‐informed Stepped Care (DiSC) to improve adolescent and young adult HIV care outcomes in Kenya: a cluster randomized trial

    by Pamela Kohler, Wenwen Jiang, Jacinta Badia, James Kibugi, Jessica Dyer, Julie Kadima, Dorothy Oketch, Kristin Beima‐Sofie, Sarah Hicks, Barbra A. Richardson, et al.

    Introduction: Systematic use of data‐driven tools to allocate care services based on needs, including differentiated care for stable individuals and intensive care for those with higher risk, may improve retention and viral suppression in adolescents and young adults living with HIV (AYLHIV).Methods: This cluster randomised trial in western Kenya tested a data‐informed stepped care intervention that assigned AYLHIV to four intensities of care according to need. AYLHIV at 12 intervention facilities underwent step assignment at each visit; those at lowest risk were offered differentiated models of service delivery (DSD), and those with risk factors more intensive services. AYLHIV at control sites received standard care. AYLHIV were followed for 12 months. Clinical and viral load data were abstracted from medical records. The primary outcome was the proportion of missed visits (defined as > 30 days late for scheduled visit). Secondary outcomes included loss to follow‐up, viral non‐suppression and assignment to DSD (multi‐month refills or pharmacy fast‐track visits). Mixed effects regression was clustered by individual and facility and adjusted for outcomes during the pre‐enrolment period and baseline variables that differed by arm.Results: Between April and July 2022, 1911 AYLHIV ages 10–24 were enrolled (control: 1016, intervention: 895, 1708.8 person‐years). Median age was 17, and 1512 (79.5%) were in school. Characteristics were balanced by arm, except for a higher proportion coming to the clinic alone in control arm (68.5% vs. 61.1%, p = 0.04). At intervention facilities, using the DiSC tool, 574 (64.6%) AYLHIV were assigned to DSD, 122 (13.7%) to standard care, 100 (11.3%) to mental health and retention counselling, and 92 (10.4%) to intensive case management. Missed visits were 8.5% in intervention versus 8.3% in control (adjusted risk ratio [aRR]: 1.04, 95% CI: 0.89−1.20); viral non‐suppression (7.7% vs. 9.7%, aRR 0.79 95% CI: 0.54−1.16) and antiretroviral therapy adherence (92.8% vs. 94.6%, aRR 0.98 95% CI: 0.94−1.02) were similar between arms. AYLHIV in the intervention arm received more fast‐track visits (aRR 1.21, 95% CI: 1.01−1.46). Intervention facilities experienced fewer scheduled appointments compared to control (aRR: 0.95, 95% CI: 0.91−0.98, p = 0.004).Conclusions: Overall, missed visits and non‐suppression were infrequent (< 10%) and did not decrease with the DiSC intervention. The DiSC intervention resulted in increased assignment to differentiated services without increasing missed visits or viral non‐suppression.


  • Brief Report: Effect of Improved Provider Communication and Adherence to Guidelines on PrEP Initiation in Kisumu Kenya

    by Melissa Rn Vera, Joseph Bsc Sila, Barbra A. Richardson, Felix Ba Otieno, George Bsn Owiti, Valarie Bsn Kemunto, John MBChB Kinuthia, Kristin Beima-Sofie, Anna Larsen, Julia C. Dettinger, et al.

    Introduction: Adolescent girls and young women (AGYW) in Kenya have low pre-exposure prophylaxis (PrEP) initiation rates in part because of stigmatizing interactions with health care providers. Our recent randomized clinical trial of a standardized patient actor (SP) training intervention for providers found higher quality PrEP delivery at intervention sites; however, it was unclear whether improved service quality improved PrEP initiation. Methods: This analysis used routine records from facilities participating in the randomized trial that aimed to improve provider communication and adherence to Kenyan guidelines when offering PrEP to AGYW. We used facility-level PrEP registers from May to December 2019 as the baseline period and December 2020 to June 2021 as the postintervention period. We used linear regression with percentage initiating as the outcome, intervention and baseline initiation levels as covariates, and the number eligible postintervention at each facility as frequency weights. Results: Overall, 1375 AGYW presented to study sites, were eligible for PrEP, and were included in analyses (baseline: n = 706, postintervention: n = 669). Among 669 PrEP-eligible AGYW in the postintervention period (intervention: n = 360, control: n = 309), 591 (88.3%) initiated PrEP (intervention: n = 335, control: n = 256). PrEP initiation was 93.1% at intervention sites (range: 0%–100%) and 82.8% at control sites (range: 0%–100%). Adjusted for baseline initiation rates, initiation was 12.1% higher at intervention sites than at control sites (P < 0.001, [95% CI: 0.09 to 0.15]). Conclusions: Our study found significant improvement in PrEP initiation among AGYW who presented to intervention facilities. SP training interventions that improve quality of service delivery for AGYW could lead to higher population-level PrEP coverage.


  • Open Access

    “I was given PrEP, but had no privacy”: Mystery shopper perspectives of PrEP counseling for adolescent girls and young women in Kisumu County, Kenya

    by Melissa Vera, Helen Aketch, Caroline Omom, Felix Otieno, George Owiti, Joseph Sila, John Kinuthia, Kristin Beima-Sofie, Jillian Pintye, Valarie Kemunto, et al.

    Pre-exposure prophylaxis (PrEP) is being scaled up to prevent HIV acquisition among adolescent girls and young women (AGYW) in Eastern and Southern Africa. In a prior study more than one-third of AGYW ‘mystery shoppers’ stated they would not return to care based on interactions with health providers. We examined the experiences of AGYW in this study to identify main barriers to effective PrEP services. Unannounced patient actors (USP/‘mystery shoppers’) posed as AGYWs seeking PrEP using standardized scenarios 8 months after providers had received training to improve PrEP services. We conducted targeted debriefings using open-ended questions to assess PrEP service provision and counseling quality with USPs immediately following their visit. Debriefings were audio-recorded and transcribed. Transcripts were analyzed using thematic analysis to explore why USPs reported either positive or negative encounters. We conducted 91 USP debriefings at 24 facilities and identified three primary influences on PrEP service experiences: 1) Privacy improved likelihood of continuing care, 2) respectful attitudes created a safe environment for USPs, and 3) patient-centered communication improved the experience and increased confidence for PrEP initiation among USPs. Privacy and provider attitudes were primary drivers that influenced decision-making around PrEP in USP debriefs. Access to privacy and improving provider attitudes is important for scale-up of PrEP to AGYW.


  • Open Access

    Using FRAME to characterize provider‐identified adaptations to a stepped care intervention for adolescents and youth living with HIV in Kenya: a mixed methods approach

    by Nok Chhun, Dorothy Oketch, Kawango Agot, Dorothy I. Mangale, Jacinta Badia, James Kibugi, Wenwen Jiang, Mary Kirk, Barbra A. Richardson, Pamela K. Kohler, et al.

    Introduction: The Data‐informed Stepped Care (DiSC) study is a cluster‐randomized trial implemented in 24 HIV care clinics in Kenya, aimed at improving retention in care for adolescents and youth living with HIV (AYLHIV). DiSC is a multi‐component intervention that assigns AYLHIV to different intensity (steps) of services according to risk. We used the Framework for Reporting Adaptations and Modifications‐Expanded (FRAME) to characterize provider‐identified adaptations to the implementation of DiSC to optimize uptake and delivery, and determine the influence on implementation outcomes.Methods: Between May and December 2022, we conducted continuous quality improvement (CQI) meetings with providers to optimize DiSC implementation at 12 intervention sites. The meetings were guided by plan‐do‐study‐act processes to identify challenges during early phase implementation and propose targeted adaptations. Meetings were audio‐recorded and analysed using FRAME to categorize the level, context and content of planned adaptations and determine if adaptations were fidelity consistent. Providers completed surveys to quantify perceptions of DiSC acceptability, appropriateness and feasibility. Mixed effects linear regression models were used to evaluate these implementation outcomes over time.Results: Providers participated in eight CQI meetings per facility over a 6‐month period. A total of 65 adaptations were included in the analysis. The majority focused on optimizing the integration of DiSC within the clinic (83%, n = 54), and consisted of improving documentation, addressing scheduling challenges and improving clinic workflow. Primary reasons for adaptation were to align delivery with AYLHIV needs and preferences and to increase reach among AYLHIV: with reminder calls to AYLHIV, collaborating with schools to ensure AYLHIV attended clinic appointments and addressing transportation challenges. All adaptations to optimize DiSC implementation were fidelity‐consistent. Provider perceptions of implementation were consistently high throughout the process, and on average, slightly improved each month for intervention acceptability (β = 0.011, 95% CI: 0.002, 0.020, p = 0.016), appropriateness (β = 0.012, 95% CI: 0.007, 0.027, pp = 0.005).Conclusions: Provider‐identified adaptations targeted improved integration into routine clinic practices and aimed to reduce barriers to service access unique to AYLHIV. Characterizing types of adaptations and adaptation rationale may enrich our understanding of the implementation context and improve abilities to tailor implementation strategies when scaling to new settings.


  • Patient actor training improves preexposure prophylaxis delivery for adolescent girls and young women in Kenya: a cluster randomized trial

    by Pamela Kohler, Anna Larsen, Felix Abuna, George Owiti, Joseph Sila, Tamara Owens, Valarie Kemunto, Harrison Lagat, Melissa Vera, Barbra A. Richardson, et al.

    Objective: To evaluate effectiveness of a standardized patient actor (SP) training intervention to improve quality of preexposure prophylaxis (PrEP) services for adolescent girls and young women (AGYW) in Kenya. Design: Cluster randomized trial and mystery shopper evaluation. Methods: Twelve of 24 maternal child health and family planning facilities were randomized to SP training. Providers at intervention facilities participated in 2-day training in adolescent health, PrEP guidelines, values clarification, and communication skills, followed by role-playing and de-briefing with trained actors. Control facilities received standard national training. The primary outcome was quality of care, assessed by unannounced SPs (USPs) or “mystery shoppers” blinded to intervention arm. Quality was measured in two domains: guideline adherence and communication skills. Intent to treat analysis compared postintervention quality scores by randomization arm, clustering on facility, and adjusting for baseline scores and USP. Results: Overall, 232 providers consented to USP visits, and 94 providers completed the training. Following training, USPs posed as AGYW seeking PrEP in 142 encounters (5–6 encounters per site). The mean quality score was 73.6% at intervention sites and 58.4% at control sites [adjusted mean difference = 15.3, 95% confidence interval (CI): 9.4–21.1, P < 0.001]. Mean guideline adherence scores were 57.2% at intervention sites and 36.2% at control sites (adjusted mean difference = 21.0, 95% CI: 12.5–29.4, P < 0.001). Mean communication scores were 90.0% at intervention sites and 80.5% at control sites (adjusted mean difference = 9.5, 95% CI: 5.5–13.6, P < 0.001). Conclusions: SP training significantly improved quality of PrEP care for AGYW in Kenya. Incorporating SP training and unannounced SP evaluation could improve PrEP uptake among AGYW.


  • Open Access

    The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya

    by Victor MBChB Omollo, Magdaline Bsc Asewe, Peter Bsc Mogere, Gakuo Bsc Maina, Alexandra P. PharmDc Kuo, Josephine Odoyo, Kevin Ma Oware, Jared M. Baeten, Pamela Bsn Kohler, Tamara Owens, et al.

    Background: HIV pre-exposure prophylaxis (PrEP) delivery at private pharmacies is a promising new differentiated service delivery model that may address barriers to PrEP delivery at public health care facilities. We measured the fidelity of this model (ie, delivery as intended) in a pilot study in Kenya. Setting: Five private, retail pharmacies in Kisumu and Thika Counties. Methods: Trained pharmacy providers delivered PrEP services, including identifying eligible clients, counseling on HIV risk, assessing PrEP safety, testing for HIV, and dispensing PrEP. Pharmacy clients completed surveys that assessed the fidelity of the services received after each visit. Standardized client actors (ie, mystery shoppers) were trained on 4 different case scripts, then made unannounced pharmacy visits, and then completed a 40-item checklist that assessed the fidelity and quality of service delivery components. Results: From November 2020 to December 2021, 287 clients initiated and 159 (55%) refilled PrEP. At initiation, most clients were counseled on PrEP adherence (99%, 284 of 287) and potential side effects (97%, 279 of 287) and all received provider-assisted HIV self-testing before PrEP dispensing (findings consistent across refill visits). Nine standardized client actors completed 15 pharmacy visits. At each visit, most actors were asked about their behaviors associated with HIV risk (80%, 12/15) and all were counseled on PrEP safety and side effects. All actors reported that pharmacy providers treated them with respect. Conclusions: In this first pilot study of pharmacy-delivered PrEP services in Africa, the fidelity of service delivery was high, suggesting that trained providers at private pharmacies can deliver quality PrEP services.